Hypertension, proteinuria, and palmar–plantar erythrodysesthesia (hand–foot) syndrome are among the most common AEs associated with non-selective TKIs that have anti-VEGF activity and, to a lesser extent, with the anti-VEGFR monoclonal antibody ramucirumab [19]. The gene discussed is VEGFA; the disease is hypertensive disorder.